The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS.
The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS. The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS. Moneycontrol Latest News Read More
